Insulin pumps in children - a systematic review

Mohammed Al-Beltagi1,2,3, Nermin Kamal Saeed4,5, Adel Salah Bediwy6,7

  • 1Department of Pediatrics, Faculty of Medicine, Tanta University, Tanta 31511, Algharbia, Egypt.

Insights

Insulin pump therapy offers children with diabetes mellitus better glycemic control with fewer needles. This review covers pump history, use, and benefits for pediatric diabetes management.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Mellitus Management
  • Medical Device Technology

Background:

  • Insulin pump therapy represents a significant advancement in managing diabetes mellitus, especially in pediatric populations.
  • It enables precise insulin delivery, reducing the need for frequent injections and improving metabolic control for optimal growth and development.
  • Effective use necessitates comprehensive education for children and caregivers regarding insulin pump management.

Purpose of the Study:

  • To review the historical development of insulin pumps.
  • To outline indications, types, and proper usage guidelines for pediatric insulin pump therapy.
  • To discuss challenges, care, and the advantages/disadvantages of insulin pumps in children.

Main Methods:

  • A comprehensive literature search of electronic databases was performed.
  • Searches focused on insulin pump therapy in children, with English-language publications included.
  • Data collection concluded on June 30, 2022.

Main Results:

  • A total of 118 articles were included in the review.
  • The included literature comprised 61 reviews, systemic reviews, and meta-analyses.
  • Additionally, 47 primary research studies and 10 guidelines were analyzed.

Conclusions:

  • Insulin pumps offer a less invasive method for insulin delivery, utilizing smaller doses.
  • They provide a flexible and convenient approach to physiological insulin modification, mimicking the human pancreas.
  • This therapy facilitates optimal glycemic control, mitigating risks of metabolic derangements in pediatric patients.
Abstract

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
226
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
250
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
474
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.4K